Literature DB >> 26428229

[KRAS mutations and survival after resection of colorectal liver metastases].

P Mroczkowski1, C J Bruns2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26428229     DOI： 10.1007/s00104-015-0092-y

Source DB:  PubMed          Journal:  Chirurg        ISSN： 0009-4722            Impact factor:   0.955


× No keyword cloud information.
  3 in total

1.  Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases.

Authors:  Y Fong; J Fortner; R L Sun; M F Brennan; L H Blumgart
Journal:  Ann Surg       Date:  1999-09       Impact factor: 12.969

2.  Value of mismatch repair, KRAS, and BRAF mutations in predicting recurrence and benefits from chemotherapy in colorectal cancer.

Authors:  Gordon Hutchins; Katie Southward; Kelly Handley; Laura Magill; Claire Beaumont; Jens Stahlschmidt; Susan Richman; Philip Chambers; Matthew Seymour; David Kerr; Richard Gray; Philip Quirke
Journal:  J Clin Oncol       Date:  2011-03-07       Impact factor: 44.544

3.  BRAF mutation predicts for poor outcomes after metastasectomy in patients with metastatic colorectal cancer.

Authors:  Rona Yaeger; Andrea Cercek; Joanne F Chou; Brooke E Sylvester; Nancy E Kemeny; Jaclyn F Hechtman; Marc Ladanyi; Neal Rosen; Martin R Weiser; Marinela Capanu; David B Solit; Michael I D'Angelica; Efsevia Vakiani; Leonard B Saltz
Journal:  Cancer       Date:  2014-04-15       Impact factor: 6.860
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.